Case Reports

Pheochromocytoma: An Incidental Finding in an Asymptomatic Older Adult With Renal Oncocytoma

A high index of suspicion for pheochromocytoma is necessary during the workup of secondary hypertension as untreated pheochromocytoma may lead to significant morbidity and mortality, especially in patients who require any surgical treatment.

Author and Disclosure Information

 

References

Pheochromocytoma is a rare catecholamine-secreting tumor of chromaffin cells of the adrenal medulla or sympathetic ganglia, occurring in about 0.2 to 0.5% of patients with hypertension.1-3 However, in a review of 54 autopsy-proven cases of pheochromocytoma, about 50% of the patients with hypertension were not clinically suspected for pheochromocytoma.4

Pheochromocytoma is usually diagnosed based on symptoms of hyperadrenergic spells, resistant hypertension, especially in the young, with a pressor response to the anesthesia stress test and adrenal incidentaloma.

The classic triad of symptoms associated with pheochromocytoma includes episodic headache (90%), sweating (60-70%), and palpitations (70%).2,5 Sustained or paroxysmal hypertension is the most common symptom reported in about 95% of patients with pheochromocytoma. Other symptoms include pallor, tremors, dyspnea, generalized weakness, orthostatic hypotension, cardiomyopathy, or hyperglycemia.6 However, about 10% of patients with pheochromocytoma are asymptomatic or mildly symptomatic.7 Secondary causes of hypertension are usually suspected in multidrug resistant or sudden early onset of hypertension.8

Approximately 10% of catecholamine-secreting tumors are malignant.9-11 Benign and malignant pheochromocytoma have a similar biochemical and histologic presentation and are differentiated based on local invasion into the surrounding tissues and organs (eg, kidney, liver) or distant metastasis.

A high index of suspicion is necessary during the workup of secondary hypertension as untreated pheochromocytoma may lead to significant morbidity and mortality, especially in patients who require surgical treatment.4,12 Multiple cases of hypertensive crisis, pulmonary edema, cardiac arrhythmia, and cardiogenic shock are reported in undiagnosed patients with pheochromocytoma undergoing both adrenal or nonadrenal surgery who were not medically prepared with α- and β-adrenergic antagonists and fluids before surgery.13,14

A typical workup of a suspected patient with pheochromocytoma includes biochemical tests, including measurements of urinary and fractionated plasma metanephrines and catecholamine. Patients with positive biochemical tests should undergo localization of the tumor with an imaging study either with an adrenal/abdominal magnetic resonance imaging (MRI) or computed tomography (CT) scan. If a patient has paraganglioma or an adrenal mass > 10 cm or negative abdominal imaging with a positive biochemical test, further imaging with an iobenguane I-123 scan is needed (Figure 1).

Workup of Suspected Pheochromocytoma

In this article, we present an unusual case of asymptomatic pheochromocytoma in a patient with right-sided renal oncocytoma who underwent an uneventful nephrectomy and adrenalectomy.

Pages

Recommended Reading

Empagliflozin a winner in challenging arena of stabilized acute HF
Federal Practitioner
Advanced CKD doesn’t derail empagliflozin in EMPEROR-preserved
Federal Practitioner
Predicting cardiac shock mortality in the ICU
Federal Practitioner
Does vitamin D benefit only those who are deficient?
Federal Practitioner
SGLT2 inhibitor use tied to fewer atrial arrhythmias
Federal Practitioner
AHA statement on impact of major life events on physical activity
Federal Practitioner
Care via video teleconferencing can be as effective as in-person for some conditions
Federal Practitioner
Apixaban outmatches rivaroxaban for VTE in study
Federal Practitioner
New data on rare myocarditis after COVID-19 vaccination
Federal Practitioner
D-dimer thresholds rule out PE in meta-analysis
Federal Practitioner

Related Articles